MorphoSys' vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Investor Contact

Dr. Julia Neugebauer

Director Corporate Communications & Investor Relations

Phone: +49 89 89927 179

Email Contact
LinkedIn-Profile

Media Contact

Dr. Anca Ammon

Associate Director Corporate Communications & Investor Relations

Phone: +49 89 89927 26738

Email Contact
LinkedIn-Profile

Dr. Verena Kupas

Associate Director Corporate Communications & Investor Relations

Phone: +49 89 89927 26814

Email Contact
LinkedIn-Profile